Evaluation of islet transplantation from non-heart beating donors

American Journal of Transplantation

Volumn 6, Issue 10, 2006, Pages 2476-2482

  Noguchi, H ^a,b,c   Iwanaga, Y ^a,b   Okitsu, T ^a,b   Nagata, H ^a,b   Yonekawa, Y ^a,b   Matsumoto, S ^a,d  

^a Diabetes Research Institute Japan   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

score; Islet transplantation; Kyoto islet isolation method; Non heart beating donors

Indexed keywords

AUTOANTIBODY; C PEPTIDE; HEMOGLOBIN A1C;

ADULT; ARTICLE; BLOOD CHEMISTRY; CELL FUNCTION; CONTROLLED STUDY; DONOR SELECTION; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HEART BEAT; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; ISOLATION PROCEDURE; MALE; ORGAN DONOR; PANCREAS ISLET TRANSPLANTATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SCORING SYSTEM; VALIDATION PROCESS;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; LENGTH OF STAY; MALE; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; TISSUE DONORS; TREATMENT OUTCOME;

EID: 33748487427     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01499.x     Document Type: Article

References (26)

1. Shapiro AM, Lakey JR, Ryan EA et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-238.
2. Ricordi C. Islet transplantation: A brave new world. Diabetes 2003; 52: 1595-1603.
3. Shapiro AM, Lakey JR, Paty BW, Senior PA, Bigam DL, Ryan EA. Strategic opportunities in clinical islet transplantation. Transplantation 2005; 79: 1304-1307.
4. Shapiro AM, Ricordi C, Hering B. Edmonton's islet success has indeed been replicated elsewhere. Lancet 2003; 362: 1242.
5. Noguchi H, Bonner-Weir S, Wei FY, Matsushita M, Matsumoto S. BETA2/NeuroD protein can be transduced into cells due to an arginine- and lysine-rich sequence. Diabetes 2005; 54: 2859-2866.
6. Noguchi H, Nakai Y, Matsumoto S et al. Cell permeable peptide of JNK inhibitor prevents islet apoptosis immediately after isolation and improves islet graft function. Am J Transplant 2005; 5: 1848-1855.
7. Noguchi H, Kaneto H, Weir GC, Bonner-Weir S. PDX-1 protein containing its own antennapedia-like protein transduction domain can transduce pancreatic duct and islet cells. Diabetes 2003; 52: 1732-1737.
8. Noguchi H, Matsushita M, Matsumoto S, Lu YF, Matsui H, Bonner-Weir S. Mechanism of PDX-1 protein transduction. Biochem Biophys Res Commun 2005; 332: 68-74.
9. Noguchi H, Matsumoto S, Okitsu T et al. PDX-1 protein is internalized by lipid raft-dependent macropinocytosis. Cell Transplant 2005; 14: 637-645.
10. Noguchi H, Matsushita M, Okitsu T et al. A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nat Med 2004; 10: 305-309.
11. Markmann JF, Deng S, Desai NM et al. The use of non-heart-beating donors for isolated pancreatic islet transplantation. Transplantation 2003; 75: 1423-1429.
12. Matsumoto S, Okitsu T, Iwanaga Y et al. Successful islet transplantation from non-heart-beating donor pancreata using modified Ricordi islet isolation method. Transplantation. (in press).
13. Matsumoto S, Okitsu T, Iwanaga Y et al. Insulin independence after living-donor distal pancreatectomy and islet allotransplantation. Lancet 2005; 365: 1642-1644.
14. Nagata H, Matsumoto S, Okitsu T et al. Procurement of the human pancreas for pancreatic islet transplantation from marginal cadaver donors. Transplantation. (in press).
15. Noguchi H, Ueda M, Nakai Y et al. Modified two-layer preservation method (M-Kyoto/PFC) improves islet yields in islet isolation. Am J Transplant 2006; 6: 496-504.
16. Ryan EA, Paty BW, Senior PA, Lakey JR, Bigam D, Shapiro AM. Beta-score: An assessment of beta-cell function after islet transplantation. Diabetes Care 2005; 28: 343-347.
17. Sawada T, Matsumoto I, Nakano M, Kirchhof N, Sutherland DE, Hering BJ. Improved islet yield and function with ductal injection of University of Wisconsin solution before pancreas preservation. Transplantation 2003; 75: 1965-1969.
18. Matsumoto S, Qualley SA, Goel S et al. Effect of the two-layer (University of Wisconsin solution-perfluorochemical plus O2) method of pancreas preservation on human islet isolation, as assessed by the Edmonton Isolation Protocol. Transplantation 2002; 74: 1414-1419.
19. Ricordi C, Gray DW, Hering BJ et al. Islet isolation assessment in man and large animals. Acta Diabetol Lat 1990; 27: 185-195.
20. Bank HL. Rapid assessment of islet viability with acridine orange and propidium iodide. In Vitro Cell Dev Biol 1988; 24: 266-273.
21. Baidal DA, Froud T, Ferreira JV, Khan A, Alejandro R, Ricordi C. The bag method for islet cell infusion. Cell Transplant 2003; 12: 809-813.
22. Noguchi H, Matsumoto S, Matsushita M et al. Immunosuppression for islet transplantation. Acta Med Okayama 2006; 60: 71-76.
23. Froud T, Ricordi C, Baidal DA et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 2005; 5: 2037-2046.
24. Lakey JR, Warnock GL, Rajotte RV et al. Variables in organ donors that affect the recovery of human islets of Langerhans. Transplantation 1996; 61: 1047-1053.
25. Matsumoto S, Zhang G, Qualley S et al. Analysis of donor factors affecting human islet isolation with current isolation protocol. Transplant Proc 2004; 36: 1034-1036.
26. Bosi E, Braghi S, Maffi P et al. Autoantibody response to islet transplantation in type 1 diabetes. Diabetes 2001; 50: 2464-2471.